aTyr Pharma announced the appointment of Jayant Aphale, Ph.D., as Vice President, Technical Operations. Dr. Aphale will serve as a member of the Company’s executive leadership team, overseeing manufacturing activities at contract development and manufacturing organizations and implementing strategies related to the continuous improvement of commercial manufacturing, supply chain management, process development of new products and product life cycle management. Prior to joining aTyr, Dr. Aphale was Vice President, RNA Manufacturing & Process Development for Sarepta Therapeutics
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATYR:
- aTyr Pharma announces research study with Stanford Medicine
- aTyr Pharma potentially poised to break out in 2025, says RBC Capital
- aTyr Pharma completes enrollment in Phase 3 EFZO-FIT study
- aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
Questions or Comments about the article? Write to editor@tipranks.com